Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Clinical trial NCT03127267 · RECRUITING

Trial details

NCT number: NCT03127267
Sponsor: AB Science
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-02-02
Primary completion: 2027-12-01
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.